Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Mylonakis

Showing results (391-400 of 412) with videos related to

Pageof 42
Sort By:
Open Forum Infectious Diseases|October 29, 2020
Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center ExperienceMarkos Kalligeros, Karen T Tashima, Evangelia K Mylona, et al.
Nature|March 29, 2018
A new class of synthetic retinoid antibiotics effective against bacterial persistersWooseong Kim, Wenpeng Zhu, Gabriel Lambert Hendricks, et al.
Journal of Advanced Research|July 17, 2018
Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activitiesAna María Garzón Porras, Bruna Silva Terra, Taniris Cafiero Braga, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth White, et al.
Vaccine|April 28, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth M White, et al.
MMWR. Morbidity and Mortality Weekly Report|January 26, 2023
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022David H Canaday, Oladayo A Oyebanji, Elizabeth M White, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2019
A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant <i>Staphylococcus aureus</i>Wooseong Kim, Guijin Zou, Taylor P A Hari, et al.
Plos Medicine|July 7, 2025
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trialsKirk U Knowlton, Lianne K Siegel, Christina E Barkauskas, et al.
Journal of the Pediatric Infectious Diseases Society|October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 42

Showing results (391-400 of 412) with videos related to

Sort By:
Pageof 42
Open Forum Infectious Diseases|October 29, 2020
Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center ExperienceMarkos Kalligeros, Karen T Tashima, Evangelia K Mylona, et al.
Nature|March 29, 2018
A new class of synthetic retinoid antibiotics effective against bacterial persistersWooseong Kim, Wenpeng Zhu, Gabriel Lambert Hendricks, et al.
Journal of Advanced Research|July 17, 2018
Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activitiesAna María Garzón Porras, Bruna Silva Terra, Taniris Cafiero Braga, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth White, et al.
Vaccine|April 28, 2023
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workersClare Nugent, Yasin Abul, Elizabeth M White, et al.
MMWR. Morbidity and Mortality Weekly Report|January 26, 2023
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022David H Canaday, Oladayo A Oyebanji, Elizabeth M White, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2019
A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant <i>Staphylococcus aureus</i>Wooseong Kim, Guijin Zou, Taylor P A Hari, et al.
Plos Medicine|July 7, 2025
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trialsKirk U Knowlton, Lianne K Siegel, Christina E Barkauskas, et al.
Journal of the Pediatric Infectious Diseases Society|October 1, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19Thomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 42